{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:29:53Z","timestamp":1793456993397,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Province Capability Improvement Project through Science\uff0cTechnology and Education","award":["ZDXYS202210"],"award-info":[{"award-number":["ZDXYS202210"]}]},{"name":"The Opening Foundation of Key Laboratory","award":["JSHD2022043"],"award-info":[{"award-number":["JSHD2022043"]}]},{"name":"The Opening Foundation of Key Laboratory","award":["JSHD2022043"],"award-info":[{"award-number":["JSHD2022043"]}]},{"name":"the Jiangsu Provincial Geriatric Health Research Project","award":["grant number LKM2023005"],"award-info":[{"award-number":["grant number LKM2023005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09903-y","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T09:02:45Z","timestamp":1726477365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Surveillance of adverse events following varicella vaccine immunization in Jiangsu province, China from 2017 to 2023"],"prefix":"10.1186","volume":"24","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaLi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuanBao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"4","key":"9903_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1128\/CMR.00052-13","volume":"26","author":"A Anne","year":"2013","unstructured":"Anne A, Gershon MD, Gershon, et al. Pathogenesis and current approaches to control of varicella-zoster virus infections[J]. Clin Microbiol Rev. 2013;26(4):728\u201343.","journal-title":"Clin Microbiol Rev"},{"key":"9903_CR2","doi-asserted-by":"crossref","unstructured":"Jessica Leung, Karen R, Broder M, Marin et al. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review[J]. Expert Rev Vaccines,16(4):391\u2013400.","DOI":"10.1080\/14760584.2017.1294069"},{"key":"9903_CR3","doi-asserted-by":"crossref","unstructured":"Miaomiao Wang X, Li M, You Y, Wang et al. Epidemiological characteristics of Varicella outbreaks - China, 2006\u20132022[J].China CDC Wkly. 2023,5(52):1161\u20136.","DOI":"10.46234\/ccdcw2023.218"},{"key":"9903_CR4","doi-asserted-by":"crossref","unstructured":"Fernanda Hammes Varela. Leonardo Ara\u00fajo Pinto, Marcelo Comerlato Scotta, Global impact of varicella vaccination programs[J]. Hum Vaccin Immunother,2019,15(3):645\u2013657.","DOI":"10.1080\/21645515.2018.1546525"},{"key":"9903_CR5","doi-asserted-by":"crossref","unstructured":"Mona Marin M, Marti A, Kambhampati, Stanley M, Jeram et al. Global varicella vaccine effectiveness: a Meta-analysis[J]. Pediatrics,2016;137(3):e20153741.","DOI":"10.1542\/peds.2015-3741"},{"issue":"3","key":"9903_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jinf.2018.11.009","volume":"78","author":"E Helen","year":"2019","unstructured":"Helen E, Quinn HF, Gidding HS, Marshall R, Booy, et al. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program[J]. J Infect. 2019;78(3):220\u20135.","journal-title":"J Infect"},{"issue":"4","key":"9903_CR7","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.jinf.2022.02.006","volume":"84","author":"H Fang Liu","year":"2022","unstructured":"Fang Liu H, Wang Y, Cao. Nan Zhang.Affiliations expandEffectiveness of varicella vaccine in 1-year-old children: a matched case-control study[J]. J Infect. 2022;84(4):e25\u20137.","journal-title":"J Infect"},{"issue":"Suppl 4","key":"9903_CR8","first-page":"S431","volume":"226","author":"L Pedro","year":"2022","unstructured":"Pedro L, Moro J, Leung P, Marquez Y, Kim, et al. Safety Surveillance of Varicella Vaccines in the vaccine adverse event reporting system, United States, 2006\u20132020[J]. J Infect Dis. 2022;226(Suppl 4):S431\u201340.","journal-title":"J Infect Dis"},{"key":"9903_CR9","doi-asserted-by":"crossref","unstructured":"Gao J, Tang F, Wang Z et al. Post-marketing safety surveillance for inactivated Enterovirus 71 vaccines in Jiangsu, China from 2017 to 2019 [J]. Vaccine,2021,39(9):1415\u20139.","DOI":"10.1016\/j.vaccine.2021.01.048"},{"key":"9903_CR10","doi-asserted-by":"crossref","unstructured":"Dawei Liu W, Wu K, Li. et,al. Surveillance of adverse events following immunization in China: past, present, and future[J]. Affiliations Expand 2015 Jul,33(32):4041\u20136.","DOI":"10.1016\/j.vaccine.2015.04.060"},{"key":"9903_CR11","doi-asserted-by":"crossref","unstructured":"Bellavite P. Alberto Donzelli.Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data[J]. F1000Res,2020. Sep 28:91176.","DOI":"10.12688\/f1000research.26523.1"},{"issue":"11","key":"9903_CR12","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1080\/21645515.2021.1958608","volume":"17","author":"S Qiang Wang","year":"2021","unstructured":"Qiang Wang S, Xiu L, Yang, et al. Economic evaluation of varicella vaccination strategies in Jiangsu province, China: a decision-tree Markov model[J]. Hum Vaccin Immunother. 2021;17(11):4194\u2013202.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"9903_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12879-018-3496-8","volume":"18","author":"L Zhang","year":"2018","unstructured":"Zhang L, Ma W, Liu Y, et al. Analysis of sero-epidemiological characteristics of varicella in healthy children in Jiangsu Province. China[J] BMC Infect Dis. 2018;18(1):563.","journal-title":"China[J] BMC Infect Dis"},{"issue":"6","key":"9903_CR14","doi-asserted-by":"publisher","first-page":"2114255","DOI":"10.1080\/21645515.2022.2114255","volume":"18","author":"S Xiang","year":"2022","unstructured":"Xiang S, Zhu Y. Comparison of varicella outbreaks in schools in China during different vaccination periods[J]. Hum Vaccin Immunother. 2022;18(6):2114255.","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"9903_CR15","first-page":"1009","volume":"29","author":"Y Shi Lubin","year":"2017","unstructured":"Shi Lubin Y, Jianhui J, Yanfang, et al. Surveillance results of adverse reactions of varicella attenuated live vaccine [J]. Prev Med. 2017;29(10):1009\u201312.","journal-title":"Prev Med"},{"issue":"3","key":"9903_CR16","first-page":"356","volume":"28","author":"L Li Yuan","year":"2022","unstructured":"Li Yuan L, Li Z, Lina, et al. Surveillance on adverse events following immunization with live attenuated varicella vaccine in China, 2014\u20132020 [J]. China Vaccine Immun. 2022;28(3):356\u201361.","journal-title":"China Vaccine Immun"},{"key":"9903_CR17","unstructured":"Ran H, Liu Y, Zhang L et al. Post-marketing safety surveillance for both CRM197 and TT carrier proteins PCV13 in Jiangsu, China[J]. Front Public Health 2023 Oct 16:111272562."},{"issue":"5","key":"9903_CR18","first-page":"592","volume":"48","author":"ZN Bu","year":"2022","unstructured":"Bu ZN, Sun LM, Zhao ZJ, et al. Surveillance of adverse events following immunization with herpes zoster vaccine in Guangdong province from 2020 to 2021 [J]. South China Prev Med. 2022;48(5):592\u20135.","journal-title":"South China Prev Med"},{"key":"9903_CR19","doi-asserted-by":"crossref","unstructured":"Cunninghame J, Wen S, Dufficy M et al. Immunogenicity and safety of vaccination in children with paediatric rheumatic diseases: a scoping review[J]. Ther Adv Vaccines Immunother 2023 Apr 25:112515.","DOI":"10.1177\/25151355231167116"},{"issue":"2","key":"9903_CR20","first-page":"396","volume":"42","author":"Z Lili Huang","year":"2024","unstructured":"Lili Huang Z, Chen Y, Song, et al. Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: a randomized, double-blind. Controlled study[J] Vaccine. 2024;42(2):396\u2013401.","journal-title":"Controlled study[J] Vaccine"},{"key":"9903_CR21","doi-asserted-by":"crossref","unstructured":"Anne A, Gershon MD, Gershon ED, Shapiro et al. Live attenuated Varicella Vaccine: Prevention of Varicella and of Zoster[J]. J Infect Dis 2021, 30;224:S387\u201397.","DOI":"10.1093\/infdis\/jiaa573"},{"issue":"7","key":"9903_CR22","doi-asserted-by":"publisher","first-page":"2152256","DOI":"10.1080\/21645515.2022.2152256","volume":"18","author":"F Chen","year":"2022","unstructured":"Chen F, Pan X, Liang H. Real-world safety profile of the 9-valent human papillomavirus vaccine: a study in Zhejiang, China from 2019 to 2021[J]. Hum Vaccin Immunother. 2022;18(7):2152256.","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"9903_CR23","doi-asserted-by":"publisher","first-page":"e0291730","DOI":"10.1371\/journal.pone.0291730","volume":"18","author":"W Hu","year":"2023","unstructured":"Hu W, Jia N, Meng W, et al. Safety analysis of a live attenuated mumps vaccine in healthy adolescents in China: a phase 4, observational, open-label trial[J]. PLoS ONE. 2023;18(9):e0291730.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09903-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09903-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T09:04:15Z","timestamp":1726477455000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09903-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9903"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09903-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors promise that only the specific monitoring results will be used in the article, and no personal privacy information such as the names of any specific participants in the monitoring will be used. There was no biological sample material in this monitoring. Because this work is a routine monitoring work according to the requirements, the ethical review committee of Jiangsu Center for Disease Control and Prevention decided that there was no need for ethical review and it was not necessary to obtain written informed consent from all participants. The publication of the article takes into account the requirement of privacy protection for the participants and complies with ethical norms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"983"}}